Atropine, Sodium Cromoglycate, and Thymoxamine in PGF2α-induced Bronchoconstriction in Extrinsic Asthma

17Citations
Citations of this article
13Readers
Mendeley users who have this article in their library.

Abstract

In six patients with extrinsic bronchial asthma the inhalation of prostaglandin (PG) F2α in a small dosage produced significant bronchoconstriction, whereas PGE2produced bronchodilatation. In these patients cholinergic blockade with atropine partially inhibited the PGF2α-induced bronchoconstriction, but the a-receptor-blocking drug thymoxamine and sodium cromoglycate did not. These results suggest that the effect of PGF2α is mediated through cholinergic receptors in the airways, and this effect is grossly exaggerated in asthma. The failure to inhibit PGF2α-induced bronchoconstriction with sodium cromoglycate and the observation of an inhibitory effect of sodium cromoglycate in both allergic and exercise asthma suggest that locally formed PGF2α may not be the main factor in the pathogenesis of bronchial asthma. © 1975, British Medical Journal Publishing Group. All rights reserved.

Cite

CITATION STYLE

APA

Patel, K. R. (1975). Atropine, Sodium Cromoglycate, and Thymoxamine in PGF2α-induced Bronchoconstriction in Extrinsic Asthma. British Medical Journal, 2(5967), 360–362. https://doi.org/10.1136/bmj.2.5967.360

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free